Researcher.Life Logo

npj Parkinson's Disease : Impact Factor & More

eISSN: 2373-8057pISSN: 2373-8057
JournalOpen Access

Key Metrics

CiteScore
9
Eigenfactor
0.001 - 0.005
Impact Factor
5 - 10
Scite Index
0.91 5-Year SI
SJR
Q1Neurology
SNIP
2.52
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on npj Parkinson's Disease

npj Parkinson's Disease Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher NATURE PORTFOLIO
Language English
Frequency Continuous publication
Article Processing ChargesEUR 2790 | USD 3290 | GBP 2490
Publication Time11
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
Society/Institute/SponsorParkinson's Foundation
FrequencyContinuous publication
Publication Start Year2015
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 11
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY
OA statementVisit website
View less

Planning to publish in npj Parkinson's Disease ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in npj Parkinson's Disease

Systematic evaluation of mitochondrial morphology regulators for amelioration of neuronal α-synucleinopathy.
  • 27 Jan 2026
  • NPJ Parkinson's disease
Gut bacteria composition in animal models of Parkinson's disease: a systematic review and meta-analysis.
  • 27 Jan 2026
  • NPJ Parkinson's disease
Micro-nanoplastics and Parkinson's disease: evidence and perspectives.
  • 24 Jan 2026
  • NPJ Parkinson's disease
Evaluation of the neurotrophic peptide mixture in pathogenetic therapy of patients with Parkinson's disease.
  • 23 Jan 2026
  • NPJ Parkinson's disease
Clinical utility of evoked potentials for programming subthalamic deep brain stimulation in Parkinsons disease.
  • 23 Jan 2026
  • NPJ Parkinson's disease
Optimizing Parkinson's disease progression scales using computational methods.
  • 23 Jan 2026
  • NPJ Parkinson's disease
Systematic evaluation of mitochondrial morphology regulators for amelioration of neuronal α-synucleinopathy.
  • 27 Jan 2026
  • NPJ Parkinson's disease
Gut bacteria composition in animal models of Parkinson's disease: a systematic review and meta-analysis.
  • 27 Jan 2026
  • NPJ Parkinson's disease
Micro-nanoplastics and Parkinson's disease: evidence and perspectives.
  • 24 Jan 2026
  • NPJ Parkinson's disease
Evaluation of the neurotrophic peptide mixture in pathogenetic therapy of patients with Parkinson's disease.
  • 23 Jan 2026
  • NPJ Parkinson's disease
Clinical utility of evoked potentials for programming subthalamic deep brain stimulation in Parkinsons disease.
  • 23 Jan 2026
  • NPJ Parkinson's disease
Optimizing Parkinson's disease progression scales using computational methods.
  • 23 Jan 2026
  • NPJ Parkinson's disease

FAQs on npj Parkinson's Disease